These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11228381)

  • 1. Immunopotentiation of Staphylococcus aureus type 5 capsular polysaccharide co-entrapped in liposomes with alpha-toxin.
    Burgeot C; Gilbert FB; Poutrel B
    Vaccine; 2001 Feb; 19(15-16):2092-9. PubMed ID: 11228381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus capsular polysaccharide type 5 conjugate and whole cell vaccines stimulate antibody responses in cattle.
    Tollersrud T; Zernichow L; Andersen SR; Kenny K; Lund A
    Vaccine; 2001 Jul; 19(28-29):3896-903. PubMed ID: 11427263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characteristics and conjugated antigens of ClfA A-FnBPA and CP5 in
    Li T; Huang M; Song Z; Zhang H; Chen C
    Can J Vet Res; 2018 Jan; 82(1):48-54. PubMed ID: 29382968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of a Staphylococcus aureus capsular polysaccharide-protein conjugate prepared by a low cost technique: a proof-of-concept study.
    Pujato N; Díaz G; Barbagelata MS; Vicco MH; Calvinho LF; Marcipar IS
    Appl Biochem Biotechnol; 2015 Jan; 175(1):141-54. PubMed ID: 25245681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and preclinical evaluation of two novel Staphylococcus aureus capsular polysaccharide 5 and 8-fusion protein (Hla-MntC-SACOL0723) immunoconjugates.
    Ahmadi K; Aslani MM; Pouladfar G; Faezi S; Kalani M; Pourmand MR; Ghaedi T; Havaei SA; Mahdavi M
    IUBMB Life; 2020 Feb; 72(2):226-236. PubMed ID: 31573748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adjuvants on the immune response of staphylococcal alpha toxin and capsular polysaccharide (CPS) in rabbit.
    Han HR; Park HM
    J Vet Med Sci; 2000 Mar; 62(3):237-41. PubMed ID: 10770593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity in cows of Staphylococcus aureus type 5 capsular polysaccharide-ovalbumin conjugate.
    Gilbert FB; Poutrel B; Sutra L
    Vaccine; 1994 Mar; 12(4):369-74. PubMed ID: 8178561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates.
    Park S; Gerber S; Lee JC
    Infect Immun; 2014 Dec; 82(12):5049-55. PubMed ID: 25245803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides.
    Fattom A; Li X; Cho YH; Burns A; Hawwari A; Shepherd SE; Coughlin R; Winston S; Naso R
    Vaccine; 1995 Oct; 13(14):1288-93. PubMed ID: 8585282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.
    Lattar SM; Noto Llana M; Denoël P; Germain S; Buzzola FR; Lee JC; Sordelli DO
    Infect Immun; 2014 Jan; 82(1):83-91. PubMed ID: 24126523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of alpha-toxin, capsular polysaccharide (CPS) and recombinant fibronectin-binding protein (r-FnBP) of Staphylococcus aureus in rabbit.
    Park HM; Yoo HS; Oh TH; Kim D; Han HR
    J Vet Med Sci; 1999 Sep; 61(9):995-1000. PubMed ID: 10535504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
    Camussone CM; Pujato N; Renna MS; Veaute CM; Morein B; Marcipar IS; Calvinho LF
    Vet Immunol Immunopathol; 2014 Dec; 162(3-4):96-107. PubMed ID: 25454469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.
    Cheng BL; Nielsen TB; Pantapalangkoor P; Zhao F; Lee JC; Montgomery CP; Luna B; Spellberg B; Daum RS
    Hum Vaccin Immunother; 2017 Jul; 13(7):1609-1614. PubMed ID: 28422567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.
    Liu B; Park S; Thompson CD; Li X; Lee JC
    Virulence; 2017 Aug; 8(6):859-874. PubMed ID: 27936346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.
    Skurnik D; Kropec A; Roux D; Theilacker C; Huebner J; Pier GB
    Clin Infect Dis; 2012 Nov; 55(9):1188-97. PubMed ID: 22806596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.
    Fattom A; Schneerson R; Szu SC; Vann WF; Shiloach J; Karakawa WW; Robbins JB
    Infect Immun; 1990 Jul; 58(7):2367-74. PubMed ID: 2114365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats.
    Lee JC; Park JS; Shepherd SE; Carey V; Fattom A
    Infect Immun; 1997 Oct; 65(10):4146-51. PubMed ID: 9317020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
    Uppalapati SR; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Infect Immun; 2001 Jan; 69(1):297-306. PubMed ID: 11119518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.